InvestorsHub Logo
Followers 7
Posts 467
Boards Moderated 0
Alias Born 05/25/2015

Re: None

Monday, 12/11/2017 7:12:37 AM

Monday, December 11, 2017 7:12:37 AM

Post# of 470078
Well what do you know I was right after all. I guess those that told me otherwise were quite wrong, I guess this type of study was being planned and is appropriate:

"The randomized, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY will be aimed at evaluating the safety, tolerability and efficacy of ANAVEX®2-73 in Alzheimer’s disease patients and will be conducted in both Australia and North America"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News